Comparison of GnRH agonists and antagonists in an ovular donation program;Comparación de agonistas y antagonistas de GnRH en un programa de donación ovular

Ginecologia y Obstetricia de Mexico

Volumn 72, Issue 2, 2004, Pages 53-56

  Saucedo De La Llata, Eric ^a,b   Moraga Sánchez, María Rosa ^a   Batiza Reséndiz, Víctor ^a   Santos Haliscak, Roberto ^a   Galache Vega, Pedro ^a   Hernández Ayup, Samuel ^a  

^a Inst el Estud de Concepcion Humana   (Mexico)

^b Centro de Ginecología Y Obstetricia de Monterrey   (Mexico)

Author keywords

Cetrorelix; GnRH agonist; GnRH antagonist; Oocyte donation

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; LEUPRORELIN; CETRORELIX; DRUG DERIVATIVE; FERTILITY PROMOTING AGENT; GONADORELIN; HORMONE ANTAGONIST;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FERTILIZATION; HEALTH PROGRAM; HUMAN; INFERTILITY THERAPY; OOCYTE; OVARY HYPERSTIMULATION; ADULT; BLOOD; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; FERTILIZATION IN VITRO; INFERTILITY; METHODOLOGY; NIDATION; OOCYTE DONATION; OVULATION INDUCTION; PHYSIOLOGY; PREGNANCY; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; EMBRYO IMPLANTATION; ESTRADIOL; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; INFERTILITY; LEUPROLIDE; OOCYTE DONATION; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; PREGNANCY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 3142585439     PISSN: 03009041     EISSN: 03009041     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Rutherfoid AJ, Subak-Samph RJ, Dawson KJ. Improvement of in vitro fertilization after treatment with buserelin, an agonist of luteinising hormone releasing hormone. Br Med J 1988; 295:1765-68.
2. Felberbaum RE, Albano C, Ludwig M, et al. Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist cetrorelix according with the multiple dose protocol: a prospective uncontrolled phase III study. Hum Reprod 2000; 15: 1015-20.
3. Fluker M, Grifo J, Leader A, et al. The North American Ganirelix Study Group. Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation. Fertil Steril 2001; 75: 38-45.
4. Kol S. GnRH antagonist in ART: lower embryo implantation? Hum Reprod 2000; 15:1881-82.
5. Akman MA, Erden HF, Tosun SB, et al. Comparison of agonistic flare-up protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial. Hum Reprod 2001; 16: 868-70.
6. Ricciarelli E, Sánchez M, Martínez M, et al. Impact of the gonadotropin-releasing hormone antagonist in oocyte donation cycles. Fertil Steril 2003; 79: 1461-63.
7. Thong KJ, Young PY, Menezes Q. The administration of the GnRH antagonist, cetrorelix, to oocyte donors simplifies oocyte donation. Hum Reprod 2003; 18:1256-58.
8. De Jonge D, Macklon NS, Fauser BC. A pilot study involving minimal ovarian stimulation for in vitro fertilization: extending the "follicle-stimulating hormone window" combined with the gonadotropin-releasing hormone antagonist cetrorelix. Fertil Steril 2000; 73: 1051-54.
9. Kably-Ambe A, Ruiz AJ, Baptista AA, et al. Uso de antagonistas de GnRH (cetrorelix) en reproducción asistida: primer informe en la literatura mexicana. Ginecol Obstet Mex 2002; 70: 424-30.